Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Ibotenic acid

From PsychonautWiki Archive
Revision as of 20:38, 15 February 2025 by >Tracer (Added Categories)
Jump to navigation Jump to search

This article is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

Ibotenic acid
Chemical Nomenclature
Systematic name (S)-2-Amino-2-(3-hydroxyisoxazol-5-yl)acetic acid
Class Membership
Psychoactive class Hallucinogen
Chemical class 3-Hydroxyisoxazole / α-Amino acid
Interactions


Ibotenic acid or (S)-2-amino-2-(3-hydroxyisoxazol-5-yl)acetic acid (also referred to as ibotenate) is a psychoactive substance which occurs naturally in Amanita muscaria and related species of mushrooms. It is an analogue of the neurotransmitter glutamate, and due to its structural similarity to this neurotransmitter, acts as a non-selective glutamate receptor agonist.[citation needed]

Ibotenic acid is a powerful neurotoxin, and has been employed as a "brain-lesioning agent" through cranial injections in scientific research conducted in rats.[citation needed] The same properties have not been studied in humans, however it could very well be a human neurotoxin as well.

Chemistry

This chemistry section is incomplete.

You can help by adding to it.

Pharmacology

This pharmacology section is incomplete.

You can help by adding to it.

Subjective effects

This subjective effects section is a stub.

As such, it is still in progress and may contain incomplete or wrong information.

You can help by expanding or correcting it.

The most common symptoms include nausea, vomiting, and drowsiness. However, after the first hour symptoms begin to include confusion, euphoria, visual and auditory distortions, sensations of floating, and retrograde amnesia.

Symptoms are slightly different for children, typically beginning after 30–180 minutes. Dominant symptoms in children include ataxia, obtundation, and lethargy. Seizures are occasionally reported, however, more commonly with children.[1]

References

This article does not cite enough references.

You can help by adding some.

  1. Ibotenic acid, 2022